The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples